South East Asia Eye Health

The book covers all aspects of eye health in South-East Asia from public health to health system to education to industry in 6 sections. The World Health Organization (WHO) South-East Asia region comprises of 11 countries - Bangladesh, Bhutan, DPR Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand and Timor-Leste. This region is home to 26% of world population; there is a disproportionate amount of blindness (30.6%) and visual impairment (36%). This is a first of its kind book that discusses common conditions of visual impairment and blindness in the South-East Asia region. In addition, the book documents the current eye care industry in the region and the contribution of all eye health INGOs in eye care program planning and service delivery for many decades. Majority of the countries in the South-East Asia region are categorized in ‘middle-income country’ group. This book discusses the common challenges in these countries such as, suboptimal public expenditure in health, acute shortage of skilled eye health workforce, and rudimentary health industry. The book covers the following 6 sections: 1. Geographic description and health indices of the region 2. Health system evolved over years, including universal eye health, health financing and health management information system (HMIS) 3. Common eye problems including non-communicable disease NCD (and diabetic retinopathy), neglected tropical disease NTD (and Trachoma) 4. Health workforce in the region that includes ophthalmologists, optometrists, and allied ophthalmic personnel 5. Eye health support in the region of 13 international non-government organizations (INGOs) working for decades 6. Eye health industry in the region that includes spectacles, ophthalmic devices and equipment and the pharma industry The book would be a useful resource for ophthalmologists, all public health personnel and policy makers in eye health in the South-East Asia region specifically and all ophthalmologists and scientists interested in public health all over the world as well as for program planning to reach the 'Health for All' strategy by 2030 (United Nations Sustainable Development Goal, SDG 2030).

The number of the millions of blind in the world continues to grow, causing needless social and economic deprivation. Most of these blind can be cured, and much of the remainder prevented if all people had access to the simple and effective interventions that already exist. In this newly revised fourth edition ofEye Care in Developing Nations', t

The Report for the 2030 targets on effective coverage of eye care intends to serve as a reference point to commence monitoring progress towards the 2030 global targets that were endorsed by Member States at the 74th World Health Assembly. This report draws on key results from a comprehensive analysis of population-based eye health surveys and includes estimates of effective cataract surgery coverage (eCSC) and effective refractive error coverage (eREC) at the global level, by WHO region, sex and World Bank income level, and the relative quality gap (that is, the percentage difference between ‘effective coverage’ and ‘coverage’). It also serves to highlight key gaps in current data and presents suggestions for additional efforts required to advance the monitoring, policies and programmes for increasing the coverage of eye care interventions.

This unique book will provide readers with an understanding of innovative models of delivering both primary and secondary eye care, focusing not just on providing quality care itself, but on best practices to provide and strengthen comprehensive eye care services. A wide variety of conditions will be addressed in Innovative Approaches in the Delivery of Primary and Secondary Eye Care, including childhood blindness, cataract, diabetic retinopathy, age related macular degeneration, and refractive errors. Detailed descriptions of various models are presented for each condition, which are then followed by a discussion for incorporating integrated eye care services; highlighting the importance of health system approach in comprehensive eye care. Finally, this book provides detailed strategies to address the current practical challenges related to human resources in eye care, and methods to ensure financial sustainability in the delivery of comprehensive care. Each chapter is illustrated for understanding and clarity, and provides easy-to-read tables to further enrich the text. Covering existing models of delivering care, with a look to the future, Innovative Approaches in the Delivery of Primary and Secondary Eye Care is designed for practicing ophthalmologists, residents, public health specialists and all other affiliated professionals dedicated to strengthening avenues of integrated, comprehensive eye care.

This third volume, with three supporting editors, broadens its focus on genetic eye research from the Asian to the global scale. New efforts and a new awareness have sparked important discussions on genetic eye research, and new plans are being implemented to identify the genes responsible for numerous eye diseases. The book introduces the latest findings on genetics in eye diseases, gene therapy, and genome-wide association analysis, and the efforts of the Global Eye Genetic Consortium (GEGC). The book’s editors have been instrumental in developing strategies for discovering the new genes involved in many eye diseases. All chapters were written by leading researchers working on eye genetics from the fields of Human Genetics, Ophthalmology, Molecular Biology, Biochemistry, Sensory Sciences, and Clinical Research. Advances in Vision Research, Volume III is a major resource for all researchers, clinicians, clinical researchers, and allied eye health professionals with an interest in eye diseases around the globe.

Noncommunicable diseases (NCDs) continue to be the world’s leading cause of death and disability. This document highlights the landmarks and milestones in the development and implementation of the global NCD agenda since 2000 indicating where the world wants to be in terms of NCD prevention and control by 2030. It summarizes WHO’s actions and initiatives to support Member States in addressing NCDs and to fulfil the relevant commitments with regard to NCDs by the United Nations General Assembly following the guidance provided by the Health Assembly to realize these commitments.